A. Méiogynine, 128 III.3 128 III.3.i. Dérivés de quinazoline-2(1H) 130 III.3.k. Gossypol et ses dérivés, p.140

I. Introduction, .. Série-alkoxyquinoléine, .. Et, and I. , 144 II 148 II.1. Modélisation moléculaire150 II.2.a.i. Famille I, Famille II, p.152

.. Suzuki-miyaura and .. Catalysé-de-suzuki-miyaura, 155 II.4 Evaluation 157 III. Série alkoxy-alkylaminoquinoléine 163 III.2. Synthèse des bi-et des ter-alkoxy-alkylaminoquinoléines, Synthèse des dimères et des trimères par couplage.. 171 IV. Conclusion-Perspectives, p.175

M. Petros, A. Medek, D. G. Nettesheim, D. H. Kim, H. S. Yoon et al., Solution structure of the antiapoptotic protein bcl-2, Proceedings of the National Academy of Sciences, vol.98, issue.6, pp.3012-3017, 2001.
DOI : 10.1073/pnas.041619798

Y. Denisov, M. S. Madiraju, G. Chen, A. Khadir, P. Beauparlant et al., Solution Structure of Human BCL-w, Journal of Biological Chemistry, vol.278, issue.23, pp.21124-21128, 2003.
DOI : 10.1074/jbc.M301798200

L. Day, L. Chen, S. J. Richardson, P. J. Harrisson, D. C. Huang et al., Solution Structure of Prosurvival Mcl-1 and Characterization of Its Binding by Proapoptotic BH3-only Ligands, Journal of Biological Chemistry, vol.280, issue.6, pp.4738-4744, 2005.
DOI : 10.1074/jbc.M411434200

R. J. Suzuki, N. Youle, and . Tjandra, Structure of Bax, Cell, vol.103, issue.4, pp.645-654, 2000.
DOI : 10.1016/S0092-8674(00)00167-7

J. Chou, H. Li, G. S. Salvesen, J. Yuan, and G. Wagner, Solution Structure of BID, an Intracellular Amplifier of Apoptotic Signaling, Cell, vol.96, issue.5, pp.615-624, 1999.
DOI : 10.1016/S0092-8674(00)80572-3

A. M. Huang, H. W. Petros, S. W. Virgin, E. T. Fesik, and . Olejniczak, Solution structure of a Bcl-2 homolog from Kaposi sarcoma virus, Proceedings of the National Academy of Sciences, vol.99, issue.6, pp.3428-3433, 2002.
DOI : 10.1073/pnas.062525799

S. Azmi, Z. Wang, P. A. Philip, R. M. Mohammad, and F. H. Sarkar, Emerging Bcl-2 inhibitors for the treatment of cancer, Expert Opinion on Emerging Drugs, vol.28, issue.1, pp.59-70, 2011.
DOI : 10.1002/ijc.23610

L. Finalement and . Meilleur-résultat-est-obtenu-avec-le-système-catalytique-pd, OAc) 2 /P(tBu) 3 dans un mélange dioxane/eau à reflux 164 (essai 5) : nous n'observons pas de produit U et le dimère 43 est isolé avec un rendement de 56%. Par cette même méthode

D. B. Manning, R. Whyte, T. Martinez, S. Hunter, and . Sudarsanam, The Protein Kinase Complement of the Human Genome, Science, vol.298, issue.5600, pp.1912-1934, 2002.
DOI : 10.1126/science.1075762

S. Magnuson, Z. Wang, G. Ding, and R. Reeves, Why target PIM1 for cancer diagnosis and treatment?, Future Oncology, vol.6, issue.9, pp.1461-1478, 2010.
DOI : 10.2217/fon.10.106

T. Bachmann and . Möröy, The serine/threonine kinase Pim-1, The International Journal of Biochemistry & Cell Biology, vol.37, issue.4, pp.726-730, 2005.
DOI : 10.1016/j.biocel.2004.11.005

L. T. Aho, J. Sandholm, K. J. Peltola, H. P. Mankonen, M. Lilly et al., gatekeeper site, FEBS Letters, vol.100, issue.1-3, pp.43-49, 2004.
DOI : 10.1016/j.febslet.2004.06.050

C. Brault, F. Gasser, K. Bracher, S. Huber, J. Knapp et al., PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers, Haematologica, vol.95, issue.6, pp.1004-1015, 2010.
DOI : 10.3324/haematol.2009.017079

B. Shah, K. Pang, S. Yeoh, C. Thorn, M. B. Shing-chen et al., Potential roles for the PIM1 kinase in human cancer ??? A molecular and therapeutic appraisal, European Journal of Cancer, vol.44, issue.15, pp.2144-2151, 2006.
DOI : 10.1016/j.ejca.2008.06.044

V. Adam, M. Pogacic, R. Bendit, M. C. Chappuis, J. Nawijn et al., Targeting PIM Kinases Impairs Survival of Hematopoietic Cells Transformed by Kinase Inhibitor-Sensitive and Kinase Inhibitor-Resistant Forms of Fms-Like Tyrosine Kinase 3 and BCR/ABL, Cancer Research, vol.66, issue.7, pp.3828-3835, 2006.
DOI : 10.1158/0008-5472.CAN-05-2309

C. Schenone, M. Tintori, and . Botta, Using Insights into Pim1 Structure to Design New Anticancer Drugs, Current Pharmaceutical Design, vol.16, issue.35, pp.3964-3978, 2010.
DOI : 10.2174/138161210794454996
URL : http://doi.org/10.2174/138161210794454996

C. Qian, L. Wang, E. R. Hickey, J. Studts, K. Barringer et al., Structural Basis of Constitutive Activity and a Unique Nucleotide Binding Mode of Human Pim-1 Kinase, Journal of Biological Chemistry, vol.280, issue.7, pp.6130-6137, 2005.
DOI : 10.1074/jbc.M409123200

V. Kumar, Y. Mandiyan, C. Suzuki, J. Zhang, J. Rice et al., Crystal Structures of Proto-oncogene Kinase Pim1: A Target of Aberrant Somatic Hypermutations in Diffuse Large Cell Lymphoma, Journal of Molecular Biology, vol.348, issue.1, pp.183-193, 2005.
DOI : 10.1016/j.jmb.2005.02.039

E. Morwick and . Opin, Pim kinase inhibitors: a survey of the patent literature, Expert Opinion on Therapeutic Patents, vol.65, issue.2, pp.193-212, 2010.
DOI : 10.1016/j.jmb.2005.02.039

N. Bullock, J. E. Debreczeni, O. Y. Fedorov, A. Nelson, B. D. Marsden et al., Structural Basis of Inhibitor Specificity of the Human Protooncogene Proviral Insertion Site in Moloney Murine Leukemia Virus (PIM-1) Kinase, Journal of Medicinal Chemistry, vol.48, issue.24, pp.7604-7614, 2005.
DOI : 10.1021/jm0504858

M. Holder, C. Zemskova, M. Zhang, R. Tabrizizad, J. W. Bremer et al., Characterization of a potent and selective small-molecule inhibitor of the PIM1 kinase, Molecular Cancer Therapeutics, vol.6, issue.1, pp.163-172, 2007.
DOI : 10.1158/1535-7163.MCT-06-0397

E. Atilla-gokcumen, D. S. Williams, H. Bregman, N. Pagano, and E. Meggers, Organometallic Compounds with Biological Activity: A Very Selective and Highly Potent Cellular Inhibitor for Glycogen Synthase Kinase 3, ChemBioChem, vol.282, issue.9, pp.1443-1450, 2006.
DOI : 10.1002/cbic.200600117

K. D. Tong, S. Steward, M. Thomas, E. F. Przytulinska, V. Johnson et al., Isoxazolo[3,4-b]quinoline-3,4(1H,9H)-diones as unique, potent and selective inhibitors for Pim-1 and Pim-2 kinases: Chemistry, biological activities, and molecular modeling, Bioorganic & Medicinal Chemistry Letters, vol.18, issue.19, pp.5206-5208, 2008.
DOI : 10.1016/j.bmcl.2008.08.079

A. N. Pogacic, O. Bullock, P. Fedorov, C. Filippakopoulos, A. Gasser et al., Structural Analysis Identifies Imidazo[1,2-b]Pyridazines as PIM Kinase Inhibitors with In vitro Antileukemic Activity, Cancer Research, vol.67, issue.14, pp.6916-6924, 2007.
DOI : 10.1158/0008-5472.CAN-07-0320

S. Chen, S. Redkar, D. Bearss, W. G. Wierda, and V. Gandhi, Pim kinase inhibitor, SGI-1776, induces apoptosis in chronic lymphocytic leukemia cells, Blood, vol.114, issue.19, pp.4150-4157, 2009.
DOI : 10.1182/blood-2009-03-212852

A. C. Grey, G. W. Pierce, M. D. Bemis, C. S. Jacobs, R. Moody et al., Structure-based design of 3-aryl-6-amino-triazolo[4,3-b]pyridazine inhibitors of Pim-1 kinase, Bioorganic & Medicinal Chemistry Letters, vol.19, issue.11, pp.3019-3022, 2009.
DOI : 10.1016/j.bmcl.2009.04.061

M. Sliman, E. Blairvacq, L. Durieu, J. Meijer, D. Rodrigo et al., Identification and structure???activity relationship of 8-hydroxy-quinoline-7-carboxylic acid derivatives as inhibitors of Pim-1 kinase, Bioorganic & Medicinal Chemistry Letters, vol.20, issue.9, pp.2801-2805, 2010.
DOI : 10.1016/j.bmcl.2010.03.061

C. Xia, J. Knaak, Z. M. Ma, C. Beharry, W. Mcinnes et al., Synthesis and Evaluation of Novel Inhibitors of Pim-1 and Pim-2 Protein Kinases, Journal of Medicinal Chemistry, vol.52, issue.1, pp.74-86, 2009.
DOI : 10.1021/jm800937p

L. Akué-gédu, V. Nauton, J. Théry, P. Bain, F. Cohen et al., Synthesis, Pim kinase inhibitory potencies and in vitro antiproliferative activities of diversely substituted pyrrolo[2,3-a]carbazoles, Bioorganic & Medicinal Chemistry, vol.18, issue.18, pp.6865-6873, 2010.
DOI : 10.1016/j.bmc.2010.07.036

A. Diana, P. Martorana, A. Barraja, A. Montalbano, G. Carbone et al., Nucleophilic substitutions in the isoindole series as a valuable tool to synthesize derivatives with antitumor activity, Tetrahedron, vol.67, issue.11, pp.2072-2080, 2001.
DOI : 10.1016/j.tet.2011.01.056

V. Barraja, P. Spanò, A. Diana, G. Carbone, D. Cirrincione et al., Pyrano[2,3-e]isoindol-2-ones, new angelicin heteroanalogues, Bioorganic & Medicinal Chemistry Letters, vol.19, issue.6, pp.1711-1714, 2009.
DOI : 10.1016/j.bmcl.2009.01.096

J. Hennessy and S. L. Buchwald, Synthesis of 4,5-Dianilinophthalimide and Related Analogues for Potential Treatment of Alzheimer's Disease via Palladium-Catalyzed Amination, The Journal of Organic Chemistry, vol.70, issue.18, pp.7371-7375, 2005.
DOI : 10.1021/jo051096o

J. Janosik and . Bergman, Reactions of 2,3???-biindolyl: Synthesis of indolo[3,2-a]carbazoles, Tetrahedron, vol.55, issue.8, pp.2371-2380, 1999.
DOI : 10.1016/S0040-4020(99)00030-7

Z. Maslak, S. Yan, J. Xia, C. M. Gallucci, J. D. Hadad et al., Design, Synthesis, and Conformational Dynamics of a Gated Molecular Basket, Journal of the American Chemical Society, vol.128, issue.17, pp.5887-5894, 2006.
DOI : 10.1021/ja060534l

T. Abaev and O. V. Serduyk, Catalysis by palladium complexes: new prospects in amination of aryl and hetaryl chlorides, Russian Chemical Reviews, vol.77, issue.2, pp.177-192, 2008.
DOI : 10.1070/RC2008v077n02ABEH003736

A. Carpino, R. E. Padykula, D. E. Barr, F. H. Hall, J. G. Krause et al., Synthesis, characterization, and thermolysis of 7-amino-7-azabenzonorbornadienes, The Journal of Organic Chemistry, vol.53, issue.11, pp.2565-2572, 1988.
DOI : 10.1021/jo00246a031

F. Perepichka, M. Bendikov, H. Meng, and F. , A One-Step Synthesis of a Poly(iptycene) through an Unusual Diels???Alder Cyclization/Dechlorination of Tetrachloropentacene, Journal of the American Chemical Society, vol.125, issue.34, pp.10190-10191, 1983.
DOI : 10.1021/ja036193i

E. Mahaney, A. T. Vu, C. C. Mccomas, P. Zhang, L. M. Nogle et al., Synthesis and activity of a new class of dual acting norepinephrine and serotonin reuptake inhibitors: 3-(1H-indol-1-yl)-3-arylpropan-1-amines, Bioorganic & Medicinal Chemistry, vol.14, issue.24, pp.8455-8466, 2006.
DOI : 10.1016/j.bmc.2006.08.039

K. J. Kreher and . Herd, Stable Di- and Tetrabromo-2H-isoindoles, Angewandte Chemie International Edition in English, vol.12, issue.11, pp.739-740, 1974.
DOI : 10.1002/anie.197407391

P. Wolfe and S. L. Buchwald, Palladium-Catalyzed Amination of Aryl Triflates, The Journal of Organic Chemistry, vol.62, issue.5, pp.1264-1267, 1997.
DOI : 10.1021/jo961915s

R. Hanson and . Carlson, Bis-Silyloxydienes from Diketones., Acta Chemica Scandinavica, vol.43, pp.304-306, 1989.
DOI : 10.3891/acta.chem.scand.43-0304

S. Drager and D. F. O-'brien, Novel Synthesis of Liquid Crystalline Phthalocyanines, The Journal of Organic Chemistry, vol.65, issue.7, pp.2257-2260, 2000.
DOI : 10.1021/jo9919254

T. Ito, S. Miyake, R. Hatano, T. Shima, M. Ohara et al., Asymmetric Synthesis of Helical Poly(quinoxaline-2,3-diyl)s by Palladium-Mediated Polymerization of 1,2-Diisocyanobenzenes:?? Effective Control of the Screw-Sense by a Binaphthyl Group at the Chain-End, Journal of the American Chemical Society, vol.120, issue.46, pp.11880-11893, 1998.
DOI : 10.1021/ja982500m

C. G. Miao, M. D. Bangcuyo, U. H. Smith, and . Bunz, Derivatives of Octaethynylphenazine and Hexaethynylquinoxaline, Angewandte Chemie International Edition, vol.127, issue.4, pp.661-665, 2006.
DOI : 10.1002/anie.200502067

A. D. Neto, A. S. Lopes, M. Wüst, V. E. Costa, G. Ebeling et al., Reductive sulfur extrusion reaction of 2,1,3-benzothiadiazole compounds: a new methodology using NaBH4/CoCl2??6H2O(cat) as the reducing system, Tetrahedron Letters, vol.46, issue.40, pp.6843-6846, 2005.
DOI : 10.1016/j.tetlet.2005.08.017

J. Slade, N. F. Pelz, W. Bodnar, J. W. Lampe, and P. S. Watson, Indazoles: Regioselective Protection and Subsequent Amine Coupling Reactions, The Journal of Organic Chemistry, vol.74, issue.16, pp.6331-6334, 2009.
DOI : 10.1021/jo9006656

B. Grillet, G. Baumlová, J. F. Prévost, S. Constant, D. C. Chaumeron et al., Synthesis and bioevaluation of 22-hydroxyacuminatine analogs, Bioorganic & Medicinal Chemistry Letters, vol.18, issue.6, pp.2143-2146, 2008.
DOI : 10.1016/j.bmcl.2008.01.082

V. K. Sekar and . Singh, Efficient Method for Cleavage of Aziridines with Aromatic Amines, The Journal of Organic Chemistry, vol.64, issue.7, pp.2537-2539, 1999.
DOI : 10.1021/jo981869r

X. Wu, W. Sun, and . Sun, A highly efficient and general method for the ring-opening of aziridines with various nucleophiles in DMSO, Organic & Biomolecular Chemistry, vol.345, issue.22, pp.4231-4235, 2006.
DOI : 10.1039/b611707d

J. Huang and P. O-'brien, Two-step syntheses of 2,4,6-triisopropylbenzenesulfonyl aziridines, Tetrahedron Letters, vol.46, issue.18, pp.3253-3256, 2005.
DOI : 10.1016/j.tetlet.2005.03.013

S. Sasaki, A. K. Dalili, and . Yudin, -Arylation of Aziridines, The Journal of Organic Chemistry, vol.68, issue.5, pp.2045-2047, 2003.
DOI : 10.1021/jo020696+
URL : https://hal.archives-ouvertes.fr/in2p3-00260521

E. Tunney and J. K. Stille, Palladium-catalyzed coupling of aryl halides with (trimethylstannyl)diphenylphosphine and (trimethylsilyl)diphenylphosphine, The Journal of Organic Chemistry, vol.52, issue.5, pp.748-753, 1987.
DOI : 10.1021/jo00381a008

W. Hubbard, A. M. Piegols, and B. C. Söderberg, Palladium-catalyzed N-heteroannulation of N-allyl- or N-benzyl-2-nitrobenzenamines: synthesis of 2-substituted benzimidazoles, Tetrahedron, vol.63, issue.30, pp.7077-7085, 2007.
DOI : 10.1016/j.tet.2007.05.010

K. Fries, H. Fabel, and . Eckhardt, Untersuchungen in der Reihe des Indazols, Justus Liebig's Annalen der Chemie, vol.451, issue.1, pp.31-49, 1942.
DOI : 10.1002/jlac.19425500103

W. Bost and E. E. , The Preparation of Some Substituted Quinoxalines, Journal of the American Chemical Society, vol.70, issue.3, pp.903-905, 1948.
DOI : 10.1021/ja01183a006

E. Gavara, G. Saugues, E. Alves, F. Debiton, P. Anizon et al., Synthesis and biological activities of pyrazolo[3,4-g]quinoxaline derivatives, European Journal of Medicinal Chemistry, vol.45, issue.11, pp.5520-5526, 2010.
DOI : 10.1016/j.ejmech.2010.08.067
URL : https://hal.archives-ouvertes.fr/hal-00530614

F. R. Kerr, A. H. Wyllie, and A. R. Currie, Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics, British Journal of Cancer, vol.26, issue.4, pp.239-257, 1972.
DOI : 10.1038/bjc.1972.33

L. Moffitt, S. L. Martin, and B. Walker, From sentencing to execution ??? the processes of apoptosis, Journal of Pharmacy and Pharmacology, vol.62, issue.5, pp.547-562, 2010.
DOI : 10.1211/jpp.62.05.0001

M. Boatright and G. S. Salvesen, Mechanisms of caspase activation, Current Opinion in Cell Biology, vol.15, issue.6, pp.725-731, 2003.
DOI : 10.1016/j.ceb.2003.10.009

H. Kang and C. P. Reynolds, Bcl-2 Inhibitors: Targeting Mitochondrial Apoptotic Pathways in Cancer Therapy, Clinical Cancer Research, vol.15, issue.4, pp.1126-1132, 2009.
DOI : 10.1158/1078-0432.CCR-08-0144

W. Muchmore, M. Sattler, H. Liang, R. P. Meadows, J. E. Harlan et al., X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death, Nature, vol.381, issue.6580, pp.335-341, 1996.
DOI : 10.1038/381335a0

R. J. Suzuki, N. Youle, and . Tjandra, Structure of Bax, Cell, vol.103, issue.4, pp.645-654, 2000.
DOI : 10.1016/S0092-8674(00)00167-7

F. Van-delft and D. C. Huang, How the Bcl-2 family of proteins interact to regulate apoptosis, Cell Research, vol.60, issue.2, pp.203-213, 2006.
DOI : 10.1182/blood-2005-01-0320

N. Willis and J. M. Adams, Life in the balance: how BH3-only proteins induce apoptosis, Current Opinion in Cell Biology, vol.17, issue.6, pp.617-625, 2005.
DOI : 10.1016/j.ceb.2005.10.001

E. Rutledge, J. W. Chin, and A. Schepartz, A view to a kill: ligands for Bcl-2 family proteins, Current Opinion in Chemical Biology, vol.6, issue.4, pp.479-485, 2002.
DOI : 10.1016/S1367-5931(02)00352-6

C. A. Dias and . Stein, Potential roles of antisense oligonucleotides in cancer therapy. The example of Bcl-2 antisense oligonucleotides, European Journal of Pharmaceutics and Biopharmaceutics, vol.54, issue.3, pp.263-269, 2002.
DOI : 10.1016/S0939-6411(02)00060-7

S. S. Herbst, Oblimersen Sodium (Genasense bcl-2 Antisense Oligonucleotide): A Rational Therapeutic to Enhance Apoptosis in Therapy of Lung Cancer, Clinical Cancer Research, vol.10, issue.12, pp.4245-104, 2004.
DOI : 10.1158/1078-0432.CCR-040018

B. Liu, R. Yang, Z. Cao, and . Huang, A chemical strategy to promote helical peptide???protein interactions involved in apoptosis, Bioorganic & Medicinal Chemistry Letters, vol.15, issue.20, pp.4467-4469, 2005.
DOI : 10.1016/j.bmcl.2005.07.031

D. Walensky, A. L. Kung, I. Escher, T. J. Malia, S. Barbuto et al., Activation of Apoptosis in Vivo by a Hydrocarbon-Stapled BH3 Helix, Science, vol.305, issue.5689, pp.1466-1470, 2004.
DOI : 10.1126/science.1099191

D. Walensky, K. Pitter, J. Morash, K. Ho, S. Barbuto et al., A Stapled BID BH3 Helix Directly Binds and Activates BAX, Molecular Cell, vol.24, issue.2, pp.199-210, 2006.
DOI : 10.1016/j.molcel.2006.08.020

D. Sadowsky, M. A. Schmitt, H. Lee, N. Umezawa, S. Wang et al., :?? Critical Role of the Molecular Scaffold in Protein Surface Recognition, Journal of the American Chemical Society, vol.127, issue.34, pp.11966-11968, 2005.
DOI : 10.1021/ja053678t

A. Lugovskoy, A. I. Degterev, A. F. Fahmy, P. Zhou, J. D. Gross et al., A Novel Approach for Characterizing Protein Ligand Complexes:?? Molecular Basis for Specificity of Small-Molecule Bcl-2 Inhibitors, Journal of the American Chemical Society, vol.124, issue.7, pp.1234-1240, 2002.
DOI : 10.1021/ja011239y

D. E. Shangary and . Johnson, Recent advances in the development of anticancer agents targeting cell death inhibitors in the Bcl-2 protein family, Leukemia, vol.17, issue.8, pp.1470-1481, 2003.
DOI : 10.1038/sj.leu.2403029

F. Fotsop, F. Roussi, A. Leverrier, A. Bretéché, and F. Guéritte, Biomimetic Total Synthesis of Meiogynin A, an Inhibitor of Bcl-xL and Bak Interaction, The Journal of Organic Chemistry, vol.75, issue.21, pp.7412-7415, 2010.
DOI : 10.1021/jo101088h
URL : https://hal.archives-ouvertes.fr/hal-00538906

G. Zhang, F. Wu, T. Xie, X. Song, and . Chang, ]pyrrole-9-carbonitrile (S1) Based Molecules as Potent, Dual Inhibitors of B-Cell Lymphoma 2 (Bcl-2) and Myeloid Cell Leukemia Sequence 1 (Mcl-1): Structure-Based Design and Structure???Activity Relationship Studies, Journal of Medicinal Chemistry, vol.54, issue.4, pp.1101-1105, 2011.
DOI : 10.1021/jm101181u

M. Shallal, J. S. Faridi, and W. A. Russu, Anti-tumor pyrimidinylpiperazines bind to the prosurvival Bcl-2 protein family member Bcl-XL, Bioorganic & Medicinal Chemistry Letters, vol.21, issue.5, pp.1325-1328, 2011.
DOI : 10.1016/j.bmcl.2011.01.054

Z. Tang, S. Nikolovska-coleska, C. Qiu, J. Yang, S. Guo et al., Acylpyrogallols as Inhibitors of Antiapoptotic Bcl-2 Proteins, Journal of Medicinal Chemistry, vol.51, issue.4, pp.717-720, 2008.
DOI : 10.1021/jm701358v

Z. Trudel, J. Hua-li, R. E. Rauw, X. Y. Tiedemann, A. K. Wen et al., Preclinical studies of the pan-Bcl inhibitor obatoclax (GX015-070) in multiple myeloma, Blood, vol.109, issue.12, pp.5430-5438, 2007.
DOI : 10.1182/blood-2006-10-047951

F. Lee, P. E. Czabotar, B. J. Smith, K. Deshayes, P. M. Zobel et al., Crystal structure of ABT-737 complexed with Bcl-xL: implications for selectivity of antagonists of the Bcl-2 family, Cell Death and Differentiation, vol.10, issue.9, pp.1711-1719, 2007.
DOI : 10.1073/pnas.0701297104

N. Chonghaile and A. Letai, Mimicking the BH3 domain to kill cancer cells, Oncogene, vol.281, pp.149-157, 2009.
DOI : 10.1074/jbc.274.17.11549

H. S. Kutzki, J. T. Park, B. P. Ernst, H. Orner, A. D. Yin et al., Antagonist Based on ??-Helix Mimicry, Journal of the American Chemical Society, vol.124, issue.40, pp.11838-11839, 2002.
DOI : 10.1021/ja026861k

G. Yin, K. A. Lee, J. M. Sedey, H. Rodriguez, S. M. Wang et al., /Bak Interaction, Journal of the American Chemical Society, vol.127, issue.15, pp.5463-5468, 2005.
DOI : 10.1021/ja0446404

A. D. Yin and . Hamilton, Terephthalamide derivatives as mimetics of the helical region of Bak peptide target Bcl-xL protein, Bioorganic & Medicinal Chemistry Letters, vol.14, issue.6, pp.1375-1379, 2004.
DOI : 10.1016/j.bmcl.2003.09.096

G. Cummings and A. D. Hamilton, Disrupting protein???protein interactions with non-peptidic, small molecule ??-helix mimetics, Current Opinion in Chemical Biology, vol.14, issue.3, pp.341-346, 2010.
DOI : 10.1016/j.cbpa.2010.04.001

T. Ernst, J. Becerril, H. S. Park, H. Yin, and A. D. Hamilton, Design and Application of an ??-Helix-Mimetic Scaffold Based on an Oligoamide-Foldamer Strategy: Antagonism of the Bak BH3/Bcl-xL Complex, Angewandte Chemie International Edition, vol.42, issue.5, pp.535-539, 2003.
DOI : 10.1002/anie.200390154

M. Rodriguez and A. D. Hamilton, Benzoylurea Oligomers: Synthetic Foldamers That Mimic Extended ?????Helices, Angewandte Chemie International Edition, vol.97, issue.45, pp.8614-8617, 2007.
DOI : 10.1002/anie.200701869

M. Rodriguez, N. T. Ross, W. P. Katt, D. Dhar, G. Lee et al., /Bak Binding Interface, ChemMedChem, vol.64, issue.4, pp.649-656, 2009.
DOI : 10.1002/cmdc.200800387

H. Broch, A. Hénon, M. Debaud, N. Fogeron, F. Bonnefoy-bérard et al., Synthesis and biological activities of new di- and trimeric quinoline derivatives, Bioorganic & Medicinal Chemistry, vol.18, issue.19, pp.7132-7143, 2008.
DOI : 10.1016/j.bmc.2010.07.029
URL : https://hal.archives-ouvertes.fr/hal-00530608

B. Broch, F. Aboab, P. Anizon, and . Moreau, Synthesis and in vitro antiproliferative activities of quinoline derivatives, European Journal of Medicinal Chemistry, vol.45, issue.4, pp.1657-1662, 2010.
DOI : 10.1016/j.ejmech.2010.01.003
URL : https://hal.archives-ouvertes.fr/hal-00492914

-. Fang, R. Karisch, and M. Lautens, Efficient Syntheses of KDR Kinase Inhibitors Using a Pd-Catalyzed Tandem C???N/Suzuki Coupling as the Key Step, The Journal of Organic Chemistry, vol.72, issue.4, pp.1341-1346, 2007.
DOI : 10.1021/jo062228w

H. Zaragoza, B. Stephensen, and K. Peschke, Receptor Antagonists, Journal of Medicinal Chemistry, vol.48, issue.1, pp.306-311, 2005.
DOI : 10.1021/jm040873u

F. Slagt, A. H. De-vries, J. G. De-vries, and R. M. Kellogg, Practical Aspects of Carbon???Carbon Cross-Coupling Reactions Using Heteroarenes, Organic Process Research & Development, vol.14, issue.1, pp.30-47, 2010.
DOI : 10.1021/op900221v

A. Marsais, G. Godard, and . Queguiner, Directed ortho-lithiation of chloroquinolines. Application to synthesis of 2,3-disubstituted quinolines, Journal of Heterocyclic Chemistry, vol.9, issue.6, pp.1589-1594, 1989.
DOI : 10.1002/jhet.5570260615

A. Wegner, L. T. Scott, and A. De-meijere, A New Suzuki???Heck-Type Coupling Cascade:?? Indeno[1,2,3]-Annelation of Polycyclic Aromatic Hydrocarbons, 162 PEPPSI TM Catalyst, ChemFiles Aldrich, pp.883-887, 2003.
DOI : 10.1021/jo020367h

O. 'brien, I. Wilson, T. Orton, and F. Pognan, Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity, European Journal of Biochemistry, vol.107, issue.17, pp.5421-5426, 2000.
DOI : 10.1046/j.1432-1327.2000.01606.x